AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pacira BioSciences, Inc. Director's Dealing 2021

Jun 8, 2021

32125_dirs_2021-06-08_53591831-9170-4d45-b9c9-3c9f7e150892.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pacira BioSciences, Inc. (PCRX)
CIK: 0001396814
Period of Report: 2021-06-04

Reporting Person: STACK DAVID M (Director, CEO and Chairman)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-04	Common Stock	S	14905	$61.037	Disposed	61156	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	97273	Indirect
Common Stock	18596	Indirect
Common Stock	315	Indirect

Footnotes

F1: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.

F2: Mr. Stack and his wife are the owners of each of Three Colleens Investment, LLC and LCK Investment LLC. Mr. Stack is the general partner of Stack Schroon Mohawk FLP.